Brad Hayhow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Brad Hayhow has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Dennis Velakoulis
Melbourne Neuropsychiatry Centre, University of Melbourne and Melbourne Health, Parkville, Australia Neuropsychiatry Unit, Royal Melbourne Hospital, Parkville, Australia
6 shared publications- Frank Gaillard
Department of Radiology, The Royal Melbourne Hospital, Parkville, Australia
5 shared publications - Andrew Gleason
Neuropsychiatry Unit, Royal Melbourne Hospital, Parkville, Australia
4 shared publications - Sergio E. Starkstein
University of Western Australia
4 shared publications - Mark Walterfang
The Royal Melbourne Hospital
3 shared publications Simone Brockman
Fremantle Hospital
3 shared publications
Latest Publications
- 1 April 2019
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 27 (4) , 406-407
Apathy in Dementia: Time to StandUp
- 1 April 2019
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 27 (4) , 406-407
Apathy in Dementia: Time to StandUp
- 1 March 2018
- Published by Oxford University Press (OUP)
Biological Effects of Depression
This chapter examines the bidirectional relationship between depression and stroke. It is now clearly established that depression is a significant risk factor for stroke, and vice-versa. We review the main biological and demographic factors underlying the association between stroke and depression, the predicted mortality, the mechanism of post-stroke depression, and recent findings on its pharmacological prevention. We conclude by stressing the need for developing effective strategies to manage the burden of illness associated with these interacting conditions. As with the cardiovascular system depression has major effects on the occurrence of stroke. Morbidity and mortality are increased for patients with cerebral vascular accidents (CVA) who are depressed and is seen even in a 10-year follow-up. Depression should be treated concurrently with the management of the acute phase of a CVA.
- 1 March 2018
- Published by Oxford University Press (OUP)
Biological Effects of Depression
This chapter examines the bidirectional relationship between depression and stroke. It is now clearly established that depression is a significant risk factor for stroke, and vice-versa. We review the main biological and demographic factors underlying the association between stroke and depression, the predicted mortality, the mechanism of post-stroke depression, and recent findings on its pharmacological prevention. We conclude by stressing the need for developing effective strategies to manage the burden of illness associated with these interacting conditions. As with the cardiovascular system depression has major effects on the occurrence of stroke. Morbidity and mortality are increased for patients with cerebral vascular accidents (CVA) who are depressed and is seen even in a 10-year follow-up. Depression should be treated concurrently with the management of the acute phase of a CVA.
- 3 December 2015
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 24 (2) , 157-163
Neuroimaging in psychiatry: an update on neuroimaging in the clinical setting
Objective: We offered guidance on the role of structural and functional neuroimaging modalities for the general psychiatrist and for trainees in the clinical setting. Methods: We outlined the utility of neuroimaging modalities in the clinical setting, specifically with a view to understanding the pathophysiology of manifestations of disease. Results: Both structural and functional neuroimaging modalities have a clear role in diagnostic evaluation in the spectrum of neurodegenerative disorders. Conclusions: Whilst the role of neuroimaging in patients with mood, anxiety and psychotic disorders is less clear, structural and functional imaging modalities have utility in the clinical setting in the form of diagnostic refinement and in understanding the pathophysiology of disorders, towards explaining manifestations and planning treatment.
- 3 December 2015
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 24 (2) , 157-163
Neuroimaging in psychiatry: an update on neuroimaging in the clinical setting
Objective: We offered guidance on the role of structural and functional neuroimaging modalities for the general psychiatrist and for trainees in the clinical setting. Methods: We outlined the utility of neuroimaging modalities in the clinical setting, specifically with a view to understanding the pathophysiology of manifestations of disease. Results: Both structural and functional neuroimaging modalities have a clear role in diagnostic evaluation in the spectrum of neurodegenerative disorders. Conclusions: Whilst the role of neuroimaging in patients with mood, anxiety and psychotic disorders is less clear, structural and functional imaging modalities have utility in the clinical setting in the form of diagnostic refinement and in understanding the pathophysiology of disorders, towards explaining manifestations and planning treatment.
- Open Access
- 7 September 2015
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 50 (1) , 101-102
Cardiac 123 I-meta-iodo-benzyl-guanine in a patient with bipolar affective disorder, musical hallucinations and Parkinsonism
- 7 September 2015
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 50 (1) , 101-102
Open AccessCardiac 123 I-meta-iodo-benzyl-guanine in a patient with bipolar affective disorder, musical hallucinations and Parkinsonism
- 14 October 2014
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 49 (2) , 188-189
Neuropsychiatric presentation following acute hypoxic-ischaemic encephalopathy
- 14 October 2014
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 49 (2) , 188-189
Neuropsychiatric presentation following acute hypoxic-ischaemic encephalopathy
- 18 September 2014
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 49 (2) , 186-187
Delayed diagnosis of multiple sclerosis in a patient with schizoaffective disorder: a case of ‘diagnostic overshadowing’
- 18 September 2014
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 49 (2) , 186-187
Delayed diagnosis of multiple sclerosis in a patient with schizoaffective disorder: a case of ‘diagnostic overshadowing’
- 16 April 2014
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 48 (10) , 959-960
Neuropsychiatric symptoms as the presenting feature of acquired hepatocerebral degeneration
- 16 April 2014
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 48 (10) , 959-960
Neuropsychiatric symptoms as the presenting feature of acquired hepatocerebral degeneration
- 3 March 2014
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 48 (4) , 379-380
Communicating hydrocephalus with reversible cognitive impairment
- 3 March 2014
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 48 (4) , 379-380
Communicating hydrocephalus with reversible cognitive impairment
- 21 February 2014
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 48 (8) , 779-780
Cerebral amyloid angiopathy presenting with neuropsychiatric symptoms
- 21 February 2014
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 48 (8) , 779-780
Cerebral amyloid angiopathy presenting with neuropsychiatric symptoms
- 12 November 2013
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 48 (5) , 486-487
Frontal meningioma mimicking relapse of schizophrenia
- 12 November 2013
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 48 (5) , 486-487
Frontal meningioma mimicking relapse of schizophrenia